Healthcare of Ontario Pension Plan Trust Fund Takes $8.89 Million Position in Perrigo Company plc (NYSE:PRGO)

Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Perrigo Company plc (NYSE:PRGO) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 339,000 shares of the company’s stock, valued at approximately $8,892,000. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.25% of Perrigo at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of PRGO. Price T Rowe Associates Inc. MD lifted its position in shares of Perrigo by 5.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 103,031 shares of the company’s stock worth $3,317,000 after purchasing an additional 5,261 shares during the last quarter. Beach Investment Counsel Inc. PA acquired a new stake in Perrigo in the second quarter worth $72,000. Harbor Capital Advisors Inc. increased its position in Perrigo by 292.5% in the second quarter. Harbor Capital Advisors Inc. now owns 20,749 shares of the company’s stock worth $533,000 after buying an additional 15,463 shares during the period. CWM LLC boosted its holdings in shares of Perrigo by 877.0% during the second quarter. CWM LLC now owns 8,197 shares of the company’s stock valued at $210,000 after acquiring an additional 7,358 shares during the period. Finally, O Keefe Stevens Advisory Inc. bought a new stake in Perrigo in the 2nd quarter valued at about $3,427,000. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Perrigo Trading Down 0.1 %

Shares of PRGO opened at $28.54 on Friday. The stock has a fifty day moving average price of $26.03 and a two-hundred day moving average price of $27.07. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo Company plc has a 52-week low of $23.89 and a 52-week high of $34.60. The company has a market cap of $3.89 billion, a price-to-earnings ratio of -24.39 and a beta of 0.48.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.81 EPS for the quarter, hitting analysts’ consensus estimates of $0.81. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.12 billion. During the same period in the previous year, the firm earned $0.64 earnings per share. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. Analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Friday, November 29th will be issued a dividend of $0.276 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 annualized dividend and a yield of 3.87%. Perrigo’s payout ratio is presently -94.02%.

Insider Buying and Selling

In other news, Director Katherine C. Doyle sold 8,954 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the transaction, the director now owns 6,009 shares of the company’s stock, valued at approximately $164,045.70. This represents a 59.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

PRGO has been the topic of a number of research analyst reports. Canaccord Genuity Group reiterated a “buy” rating and set a $42.00 price objective on shares of Perrigo in a research note on Monday, September 30th. StockNews.com raised Perrigo from a “hold” rating to a “buy” rating in a report on Thursday, November 7th. Finally, Jefferies Financial Group restated a “hold” rating and set a $30.00 price objective (down previously from $50.00) on shares of Perrigo in a research report on Monday, September 23rd. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $37.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.